Health
Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo – News-Medical.Net
Researchers have developed a stable and ultrapotent homotrimeric Pittsburgh inhalable Nanobody 21 (PiN-21) against SARS-CoV-2 infection in Syrian hamsters. They…
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), are being administered worldwide. A successful, safe and targeted therapeutic drug to treat this infection is yet to emerge.
Convalescent plasma, repurposed antivirals, neutralizing monoclonal antibodies, and highly selected nanobodies (Nbs) and multivalent forms are some of the innovative therapeutics tried against this virus.
However, these attempts to arrive…
-
Business19 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News19 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business19 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News19 hours agoDid AI write your accounting expert’s report? – Proctor